Skip to main content
OpenTrials

Clinical trial condition

Blood Platelet Disorders

Explore clinical trials studying Blood Platelet Disorders. Study availability and eligibility vary by location and protocol.

957 public trials 209 recruiting studies
Refine in advanced search Browse all conditions

Blood Platelet Disorders trial results

Completed

Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

NCT02078284

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Hoxworth Blood Center Cincinnati, Ohio, United States
  • Puget Sound Blood Center Seattle, Washington, United States
  • University of Washington, Division of Hematology Seattle, Washington, United States
View Trial Details
Completed

Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery

NCT02283268

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • University of Miami, Jackson Memorial Hospital Miami, Florida, United States
  • Georgia Regents University Augusta, Georgia, United States
  • John Hopkins University Baltimore, Maryland, United States
View all 34 locations
View Trial Details
Completed

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of California Davis Cancer Center Sacramento, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Illinois College of Medicine at Peoria Peoria, Illinois, United States
  • Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
View all 52 locations
View Trial Details
Completed

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

NCT00816660

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Emory University School of Medicine, Dept. of Pediatrics Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
  • University of Kentucky Hemophilia Treatment Center Lexington, Kentucky, United States
View all 25 locations
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

NCT03164915

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Busan National University Hospital Busan, South Korea
  • Bundang Seoul National University Hospital Seongnam, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details
Completed

American Trial Using Tranexamic Acid in Thrombocytopenia

NCT02578901

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Washington Seattle, Washington, United States
View Trial Details
Completed

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

NCT03519672

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Congenital Thrombotic Thrombocytopenic Purpura, +14 more
Locations
  • AutoCruitment Atlanta, Georgia, United States
  • Houston Methodist Research Institute Houston, Texas, United States
  • Cambridge University Hospital Cambridge, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details

Related conditions